NCT07366320

Brief Summary

This study investigates whether four weeks of Rhodiola rosea supplementation can improve physical fitness, neuromuscular performance, and decision-making ability in competitive male football players. Participants are randomly assigned to receive either Rhodiola rosea or a placebo while continuing their regular football training. Before and after the four-week intervention, all participants complete a series of tests, including aerobic fitness, repeated sprint ability, jumping performance, reaction time, and soccer-specific decision-making tasks. Blood samples are also collected to assess fatigue and recovery-related markers. The purpose of this study is to determine whether Rhodiola rosea supplementation can enhance performance and cognitive function under high-intensity training and competition conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 30, 2025

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 27, 2025

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 4, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

28 days

First QC Date

January 9, 2026

Last Update Submit

January 16, 2026

Conditions

Keywords

Rhodiola roseaSoccerFootball playersDietary supplementRepeated sprint abilityDecision makingFatigueRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Yo-Yo Intermittent Recovery Test Level 2 (Yo-Yo IR2) distance

    The Yo-Yo Intermittent Recovery Test Level 2 (Yo-Yo IR2) will be used to assess high-intensity intermittent endurance capacity. The total distance completed during the test will be recorded at baseline and after 4 weeks of Rhodiola rosea or placebo supplementation.

    Time Frame: Baseline and Week 4

Secondary Outcomes (10)

  • Best sprint time during repeated sprint test

    Time Frame: Baseline and Week 4

  • Mean sprint time during repeated sprint test

    Baseline and Week 4

  • Countermovement jump (CMJ) height

    Time Frame: Baseline and Week 4

  • Decision-making reaction time

    Time Frame: Baseline and Week 4

  • Blood lactate concentration immediately post-repeated sprint exercise

    Baseline and Week 4 (immediately post-repeated sprint exercise)

  • +5 more secondary outcomes

Study Arms (2)

Rhodiola rosea Group

EXPERIMENTAL

Participants received Rhodiola rosea supplementation for 4 weeks in addition to their regular football training.

Dietary Supplement: Rhodiola rosea extract

Placebo

PLACEBO COMPARATOR

Participants consumed placebo capsules identical in appearance to Rhodiola rosea for 4 weeks.

Other: Placebo

Interventions

Rhodiola rosea extractDIETARY_SUPPLEMENT

Participants assigned to this intervention will receive Rhodiola rosea extract for 4 weeks in addition to their regular football training. The supplement will be administered orally in capsule form at a dose of 2,400 mg per day, given twice daily. The extract is standardized to salidroside, providing a total of 12 mg salidroside per daily dose. The capsules contain starch as excipient and gelatin as the capsule shell. All supplements are sourced from the same production batch to ensure consistency throughout the intervention period. Adherence will be monitored by capsule count and compliance logs.

Also known as: Rhodiola
Rhodiola rosea Group
PlaceboOTHER

Participants assigned to this intervention will receive placebo capsules identical in appearance, taste, and packaging to the Rhodiola rosea capsules for 4 weeks in addition to their regular football training. The placebo contains inert ingredients and is administered orally following the same dosing schedule as the Rhodiola rosea group.

Also known as: Placebo capsule
Placebo

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male competitive football players aged 18-30 years
  • Regular participation in structured football training (≥3 sessions per week)
  • Free from musculoskeletal injury for at least 3 months prior to the study
  • Not using any nutritional supplements or ergogenic aids for at least 4 weeks before enrollment
  • Willing to maintain habitual diet and training throughout the study
  • Provided written informed consent

You may not qualify if:

  • History of cardiovascular, metabolic, neurological, or endocrine disease
  • Use of Rhodiola rosea, caffeine, or other performance-enhancing supplements within the past 4 weeks
  • Current smoking or substance abuse
  • Known allergy to herbal supplements
  • Any injury or illness that could affect physical performance or safe participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Football Institute, Beijing Sport University

Beijing, Beijing Municipality, 100084, China

Location

MeSH Terms

Conditions

Fatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dingmeng Ren, PhD

    Beijing Sport University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Both participants and outcome assessors were blinded to group allocation. Supplements and placebo were identical in appearance and packaging.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to either Rhodiola rosea supplementation or placebo in a parallel two-arm design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduate Student

Study Record Dates

First Submitted

January 9, 2026

First Posted

January 26, 2026

Study Start

August 30, 2025

Primary Completion

September 27, 2025

Study Completion

October 4, 2025

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to participant confidentiality and institutional data protection policies.

Locations